SpineTop Stories

ALPHATEC’S HOLE DEEPENS. WHAT’S NEXT?

Robin Young • Thu, May 19th, 2016

Conditions at Alphatec have, apparently, reached the stage where a press release regarding the quarterly results is not considered necessary.

Nor, for that matter, is a call with Wall Street analysts to review the quarter.

On May 6, 2016 Alphatec Spine filed the required 10-Q financial report with the Securities and Exchange Commission (SEC). Normally, that would prompt both a press release and a call with analysts and institutional investors.

Not this time.

While management appears to have gone radio silent, rank and file Alphatec employees are lighting up anonymous web-based message boards with blistering critiques and dire warnings.

Comments like this one are being repeated in one form or another: “Pros: great benefits, good products and excellent people who work here. Cons: sales down, morale not good, no cash flow, no hiring in early 2016, not very positive work environment. Used to be better when DK was here.”

DK refers to Dirk Kuyper, CEO at Alphatec from 2007 to 2012.

Reading the tea leaves, Alphatec may be vacillating between two potential circumstances:

  1. Debt holders have replaced equity owners as the company’s most important constituency and are putting together some form of recapitalization—with our without court assistance—likely without current management.
  2. Or a buyer for Alphatec is trying to close the deal and a call with Wall Street will wait until that is wrapped up.

Reading Alphatec’s 10-Q

Alphatec’s March 2016 SEC filing is tough reading. No doubt the company’s attorneys urged management to disgorge every possible negative fact or possibility.

Here are the key points:

  • Sales for the three months ended March 31, 2016 fell 8% from the same period last year.
  • Operating earnings turned from a $1.1 million profit last year to a $3.7 million loss this year.
  • Net loss reached $6.6 million.
  • Cash at the end of the quarter was $7.8 million.
  • Total current liabilities at the end of the quarter were $130 million.
  • Total current assets at the end of the quarter were $100 million.

The following table illustrates how steadily Alphatec’s operations have deteriorated since 2013.

 

READ THE REST AT RYORTHO

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button
Close